Related Experiment Videos
The MEN1 gene and associated diseases: an update
T Tsukada1, K Yamaguchi, T Kameya
1Growth Factor Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Endocrine Pathology
|December 12, 2001
Summary
Multiple Endocrine Neoplasia type 1 (MEN1) is caused by mutations in the MEN1 tumor suppressor gene. DNA testing for these germline mutations aids in diagnosing predisposition and managing affected families.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Multiple Endocrine Neoplasia type 1 (MEN1) is an inherited cancer syndrome.
- It is characterized by tumors of the pituitary, parathyroid, and enteropancreatic glands.
- Germline mutations in the MEN1 tumor suppressor gene cause this syndrome.
Purpose of the Study:
- To review recent findings on the MEN1 gene.
- Focus on germline mutations and associated diseases.
- Discuss the role of genetic testing in MEN1 diagnosis and management.
Main Methods:
- Literature review of studies on MEN1 gene mutations.
- Analysis of genotype-phenotype correlations.
- Evaluation of diagnostic utility of MEN1 genetic testing.
Main Results:
- Various mutations in the MEN1 gene cause loss of function, leading to MEN1 and related disorders.
- No specific mutation hotspot or strong genotype-phenotype correlation exists for classical MEN1.
- Some missense mutations may be linked to familial isolated hyperparathyroidism (FIHP).
- Distinct familial endocrine tumor syndromes lacking MEN1 mutations exist.
Conclusions:
- MEN1 germline mutation testing is crucial for diagnosing predisposition to MEN1.
- Genetic testing supports patient counseling and family management.
- Understanding MEN1 mutations is key to managing this familial cancer syndrome.